Double Cord Versus Haploidentical (BMT CTN 1101)

Clinical Trial ID NCT01597778

Rank	Title	Journal	Year	PubWeight™‹?›
1	Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.	Blood	2015	2.00
2	Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.	Blood	2015	1.52
3	Modern approaches to HLA-haploidentical blood or marrow transplantation.	Nat Rev Clin Oncol	2015	1.17
4	Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies.	Biol Blood Marrow Transplant	2014	1.14
5	Reduced-intensity conditioned allogeneic SCT in adults with AML.	Bone Marrow Transplant	2015	0.96
6	Concise review: umbilical cord blood transplantation: past, present, and future.	Stem Cells Transl Med	2014	0.95
7	HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide.	Bone Marrow Transplant	2015	0.94
8	Recent developments in HLA-haploidentical transplantations.	Best Pract Res Clin Haematol	2015	0.80
9	Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer.	J Comp Eff Res	2014	0.77
10	Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies.	Adv Hematol	2016	0.75